Serious risks of the orphan drug, which received fast-track designation and priority review, include hypertension, hypertensive crisis, myelodysplastic syndrome, acute myeloid leukemia, and bone marrow suppression.
The drug carries a boxed warning about the risk of supine hypertension. ... The most common adverse events were headache, dizziness, nausea, hypertension, and fatigue.
hypertension. Although some may debate the potential causes of climate change, its effects have undeniably been felt worldwide, and it will most likely continue to play a role in health and ... Physicians should also consider whether white-coat
The results showed an increase of 24.7% in hypertension control from 1975 to 1978, an increase of 28.5% in cholesterol control from 1986 to 2010, and an increase from ... While the researchers are still crunching the numbers, the program appears to have
The trial, SIMPLICITY-HTN3, was designed to test the efficacy of renal artery denervation by radiofrequency ablation in the treatment of medication resistant hypertension.
This patient most likely has new-onset type 2 diabetes mellitus (recent-onset polyuria and nocturia, high random glucose levels) and classic features of excess mineralocorticoid activity, including hypertension, metabolic alkalosis, ... Adrenal adenomas
Azilsartan medoxomil (Edarbi) tablets, a new angiotensin II receptor blocker to treat hypertension in adults.
Those who abuse appetite suppressants may develop hypertension or anxiety, while those who abuse laxatives or diuretics may develop electrolyte abnormalities, abnormal gut motility, and secondary kidney failure. ... For patients who gain extreme amounts
Heavy drinking imposes significant risks for osteoporosis, many types of cancer, liver disease, hypertension, atrial fibrillation, stroke and multiple social and behavioral problems. ... In addition, other conditions should prompt a discussion about the
George L. Bakris, FACP, (top middle panel) leads case discussions with primary care clinicians via teleconferencing regarding management of uncontrolled hypertension. ... The University of Chicago, meanwhile, began applying Project ECHO in 2010 to an